Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 19%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 440 666 7999
Address:
581 Boston Mills Road, Suite 300, Hudson, United States
NVDAMillionaire
NVDAMillionaire Jul. 23 at 12:48 PM
$GWLL Outstanding article that hits the mark on GWLL's current state. So if you want to refresh your GWLL insights or learn about GWLL from scratch, this is a must read. https://beyondspx.com/article/goldenwell-biotech-the-capital-crucible-for-nutraceutical-ambitions-nasdaq-gwll
0 · Reply
Latest News on GWLL
No data available.
NVDAMillionaire
NVDAMillionaire Jul. 23 at 12:48 PM
$GWLL Outstanding article that hits the mark on GWLL's current state. So if you want to refresh your GWLL insights or learn about GWLL from scratch, this is a must read. https://beyondspx.com/article/goldenwell-biotech-the-capital-crucible-for-nutraceutical-ambitions-nasdaq-gwll
0 · Reply